BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 22065097)

  • 1. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
    Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
    Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
    Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
    Petersson U; Ostgren CJ; Brudin L; Nilsson PM
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus.
    Mok CC; Ho LY; To CH
    Scand J Rheumatol; 2009; 38(5):362-8. PubMed ID: 19296403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
    Grönhagen CM; Fored CM; Granath F; Nyberg F
    Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.
    Yang L; Tao J; Tang X; Wang Y; He X; Xu G; Ren Y; Tu Y
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):95-101. PubMed ID: 21851424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of systemic lupus erythematosus with a higher risk of cervical but not trochanteric hip fracture: a nationwide population-based study.
    Wang SH; Chang YS; Liu CJ; Lai CC; Chen WS; Chen TJ; Wang SJ
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1674-81. PubMed ID: 23592551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
    Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
    J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus.
    Jönsen A; Clarke AE; Joseph L; Belisle P; Bernatsky S; Nived O; Bengtsson AA; Sturfelt G; Pineau CA
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1233-7. PubMed ID: 21618451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964-95.
    Björnådal L; Yin L; Granath F; Klareskog L; Ekbom A
    J Rheumatol; 2004 Apr; 31(4):713-9. PubMed ID: 15088296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study.
    Achterberg S; Cramer MJ; Kappelle LJ; de Borst GJ; Visseren FL; van der Graaf Y; Algra A;
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):424-30. PubMed ID: 20555265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden.
    Wallberg-Jonsson S; Ohman ML; Dahlqvist SR
    J Rheumatol; 1997 Mar; 24(3):445-51. PubMed ID: 9058647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden.
    Van Hemelrijck M; Garmo H; Holmberg L; Stattin P; Adolfsson J
    Eur Urol; 2012 Apr; 61(4):690-700. PubMed ID: 21945719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk and lupus disease.
    Boucelma M; Haddoum F; Chaudet H; Kaplanski G; Mazouni-Brahimi N; Rezig-Ladjouze A; Brouri M; Berrah A
    Int Angiol; 2011 Feb; 30(1):18-24. PubMed ID: 21248669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.